John Bibb became executive vice president and general counsel of San Antonio, Texas-based KCI, and Acelity Co., in 2011 after working in-house at the medical device company for eight years as its head mergers and acquisitions attorney. He first helped the company buy LifeCell in 2008 for $1.8 billion and recently helped guide the company through its sale to 3M for $6.7 billion.

Bibb spoke to Corporate Counsel on Friday about the role of the legal department in M&A and the attempts to take the company public in 2015 and earlier this year before the sale to 3M. This conversation has been edited for clarity and length.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]